303 |
Gapanenok, D.; Makhmet, A. Peshkov, A. A.; Smirnova, D.; Amire, N.; Peshkov, V. A.; Spiridonova, D.; Dar'in, D.; Balalaie, S.; Krasavin, M. Multicomponent Assembly of Trisubstituted Imidazoles and Their Photochemical Cyclization into Fused Polyheterocyclic Scaffolds. J. Org. Chem., accepted 18.05.2022 |
302 |
Vepreva, A.; Bunev, A. S.; Kudinov, A. Yu.; Kantin, G.; Krasavin, M.; Dar'in, D. Unusual Highly Diastereoselective Rh(II)-catalyzed Dimerization of Diazo Arylidene Succinimides Provides Access to New Dibenzazulene Scaffold. Beilstein J. Org. Chem., accepted 05.05.2022 |
301 |
Krasavin, M.; Jovanović, M.; Podolski-Renić, A.; Pešić, M. The role of the thioredoxin detoxification system in cancer progression and resistance. Front. Mol. Biosci., accepted 25.04.2022 |
300 |
Ananeva, A.; Bakulina, O.; Dar'in, D.; Kantin, G.; Krasavin, M. Dicarboxylic Acid Monoesters in β- and δ-Lactam Synthesis. Molecules 2022, 27, 2469 |
299 |
Kalinin, S.; Kovalenko, A.; Valtari, A.; Nocentini, A.; Gureev, M.; Urtti, A.; Korsakov, M.; Supuran, C. T.; Krasavin, M. 5-(Sulfamoyl)thien-2-yl 1,3-Oxazole Inhibitors of Carbonic Anhydrase II with Hydrophilic Periphery. J. Enzyme Inhib. Med. Chem. 2022, 37, 1005-1011 |
298 |
Krasavin, M.; Shetnev, A.; Panova, V.; Ivanovskyi, S.; Kalinin, S.; Vinogradova, V.; Sharoyko, V.; Yablonsky, P. Hetaryl- and heteroarylvinyl-substituted nitrofurans identified as non-cytotoxic selective antitubercular agents. Mendeleev Commun., accepted 16.03.2022 |
297 |
Zhukovsky, D.; Dar'in, D.; Bakulina, O. Krasavin, M. Preparation and synthetic applications of five-to-seven-membered cyclic α-diazo monocarbonyl compounds. Molecules 2022, 27, 2030 |
296 |
Grintsevich, S.; Sapegin, A.; Krasavin, M. Heteroatom is not needed: access to dibenzo[e,h][1,4]diazecin-9-ones from dibenzo[b,e]azepin-6-one via the hydrated imidazoline ring expansion (HIRE) approach. Tetrahedron Lett., accepted 11.03.2022 |
295 |
Sharonova, T.; Zhmurov, P.; Kalinin, S.; Nocentini, A.; Angeli, A.; Ferraroni, M.; Korsakov, M.; Supuran, C.; Krasavin, M. Diversely Substituted Sulfamides for Fragment-Based Drug Discovery of Carbonic Anhydrase Inhibitors: Synthesis and Inhibitory Profile. J. Enzyme Inhib. Med. Chem. 2022, 37, 857–865 |
294 |
Chupakhin, E. G.; Krasavin, M. Natural compounds as inhibitors of thioredoxin reductase (TrxR1). Russ. Chem. Bull. 2022, 71, 443–448 |
293 |
Chupakhin, E. G.; Kantin, G. P.; Dar’in, D. D.; Krasavin, M. Novel chromeno[2,3-c]pyrroles synthesized via intramolecular rhodium(II) carbene trapping. Mendeleev Commun. 2022, 32, 382-383 |
292 |
Geyl, K. K.; Baykov, S. V.; Kalinin, S. A.; Bunev, A. S.; Troshina, M. A.; Sharonova, T. V.; Skripkin, M. Y.; Kasatkina, S. O.; Presnukhina, S. I.; Shetnev, A. A.; Krasavin, M. Y.; Boyarskiy, V. P. Synthesis, structure, and antiproliferative action of 2-pyridyl urea-based Cu(II) complexes. Biomedicines 2022, 10, 461 |
291 |
Guranova, N.; Bakulina, O.; Dar'in D.; Kantin, G.; Krasavin, M. Homophthalic Esters: A New Type of Reagents for the Castagnoli-Cushman Reaction. Eur. J. Org. Chem., accepted 09.02.2022 |
290 |
Paramonova, P.; Bakulina, O.; Nabiyev, A.; Dar'in, D.; Krasavin, M. The Castagnoli-Cushman reaction of 3-aryl glutaric acids: a convenient, diastereoselective entry into medicinally important 6-oxo-2,4-diarylpiperidine-3-carboxylic acid scaffold. ChemistrySelect, accepted 27.12.2021 |
289 |
Zhukov, A. S.; Khairutdinov, V. R.; Samtsov, A. V.; Krasavin, M.; Garabadzhiu, A. V. Preclinical Efficacy Investigation of Human Neutrophil Elastase Inhibitor Sivelestat in Animal Model of Psoriasis. Skin Health Dis., accepted 15.12.2021 |
288 |
Grintsevich, S.; Sapegin, A.; Krasavin, M. Significant Broadening of the Substrate Scope for the Hydrated Imidazoline Ring Expansion (HIRE) via the Use of Lithium Hexamethyldisylazide. Synthesis, accepted 15.12.2021 |
287 |
Vepreva, A.; Kantin, G.; Krasavin, M.; Dar'in. A General Way to Spiro-Annulated 2-Benzoxepines via Rh2(esp)2-catalyzed [5+2] Cycloaddition of Diazo Arylidene Succinimides to Ketones. Synthesis, accepted 08.12.2021 |
286 |
Peshkov, A. A.; Makhmet, A.; Bakulina, O.; Kanov, E.; Gainetdinov, R.; Peshkov, V. A.; Dar'in, D.; Krasavin, M. A general approach to spirocyclic piperidines via Castagnoli-Cushman chemistry. Synthesis, accepted 13.12.2021 |
285 |
Paramonova, P.; Sharonova, S.; Kalinin, S.; Chupakhin, E.; Bunev, A.; Krasavin, M. (E)-3-Arylidene-4-diazopyrrolidine-2,5-diones conveniently elaborated into cytotoxic compounds bearing a primary sulfonamide and a Michael acceptor moieties. Mendeleev Commun. 2022, 32, 176-177 |
284 |
Krasavin, M.; Bubyrev, A.; Kazantsev, A.; Heim, C.; Maiwald,S.; Zhukovsky, D.; Dar'in, D.; Hartmann, M. D.; Bunev, A. Replacing the Phthalimide Core in Thalidomide with Benzotriazole. J. Enzyme Inhib. Med. Chem. 2022, 37, 527-530 |
283 |
Kazantsev, A.; Krasavin, M. Ligands for Cereblon: 2017–2021 Patent Overview. Exp. Opin. Ther. Pat. 2022, 32, 171-190 |
282 |
Grintsevich, S.; Sapegin, A.; Duszyńska, B.; Bojarski, A. J.; Krasavin, M. An attempt at the hydrated imidazoline ring expansion (HIRE) of diarene-fused [1,4]diazepinones delivers selective dopamine D2 receptor ligands. Synthesis 2022, 54, 658-666 |
281 |
Firsov, A.; Bakulina, O.; Dar´in, D.; Sokolov, V.; Krasavin, M. Synthesis of γ-sultam-annelated δ-lactams via the Castagnoli-Cushman reaction of sultam-based dicarboxylic acids. J. Org. Chem. 2022, 87, 1537-1540 |